article thumbnail

Independent Pharmacists’ Unique Role During Disaster Management Efforts

Drug Topics

Similar to Phillips’ idea of planning ahead, the FDA also has detailed provisions for patients to take during power outages, floods, or other events that compromise their ability to manage their medications. “An Taking precautions for storing medications and supplies is key to being prepared,” the FDA wrote. from 1999 to 2018.

article thumbnail

How the Rise in US Pharmacy Deserts Impacts Patients’ Health

Drug Topics

More US pharmacies closed than opened in 2018–21; independent pharmacies, those in Black, Latinx communities most at risk. Stay ahead of the curve: Sign up for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox. References 1. Health Affairs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Gaps Remain in MOUD Access Across Opioid Treatment Programs

Drug Topics

In the cross-sectional study, investigators used data from the 2018 to 2024 Mental Health and Addiction Treatment Tracking Repository. However, data on low-dose initiation compared with traditional initiation is still limited.

article thumbnail

Mark Cuban Cost Plus Drugs, 9amHealth Collaborate to Make Obesity Medications Affordable

Drug Topics

Approximately 31% of people in the United States were overweight and 42% were obese in 2017 to 2018, compared with 34% and 30.5% " Obesity has risen considerably over the past 3 years, according to data from the Pew Research Center. in 1999 to 2000, respectively.

article thumbnail

FDA Softens August 2025 NDSRI Deadline—Progress Reports Now Accepted

The FDA Law Blog

Snow — Recently, FDA announced a deadline shift, although the Agency did so quietly. Confirmatory testing remains due by August 1, 2025, but FDA has now acknowledged that full implementation of mitigation strategies—such as reformulation or the addition of new specifications—may take longer. By Charles D. What does this mean?

FDA
article thumbnail

Insmed wins FDA approval for future blockbuster Brinsupri

Pharmaceutical Technology

Buy Reports Newsletters PT News Insmed wins FDA approval for future blockbuster Brinsupri Brinsupri becomes the first bronchiectasis therapy while ushering in a new class of DPP1 inhibitors. Brinsupri has been approved to treat adults and children aged 12 years and over with NCFB. GlobalData is the parent company of Pharmaceutical Technology.

FDA
article thumbnail

Initiation of Semaglutide Does Not Decrease Health Care Spending

Drug Topics

Patients were included between January 1, 2018, and January 1, 2025, and January 1, 2018, and May 1, 2025, respectively. They included data from 2 large integrated health systems, with one serving the Virginia and North Carolina area and the other covering Connecticut and Rhode Island. years at the initiation of semaglutide.